Ora, the world’s leading ophthalmic clinical research organization, today announced the launch of the Ora Clinical Intelligence Committee (CIC), a new global network of distinguished ophthalmic experts created to help innovators make smarter, more confident development program decisions. Building on Ora’s decades of ophthalmology-focused development expertise, the Ora CIC provides innovators with a structured and practical way to access expert guidance on the clinical, operational, and regulatory questions that shape successful development programs. The CIC is designed to help innovators pressure-test critical decisions, challenge assumptions, and strengthen development strategies through collaboration with world-renowned specialists across ophthalmology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260924314211/en/

The 14 inaugural CIC members include internationally recognized leaders from across the ophthalmic community.

The 14 inaugural CIC members include internationally recognized leaders from across the ophthalmic community.

Inaugural Ora Clinical Intelligence Committee Members

The inaugural CIC includes internationally recognized leaders from across the ophthalmic community:

  • Anat Loewenstein, MD, MHA

  • Carl D. Regillo, MD, FACS

  • Dale W. Usner, PhD

  • Eleonora (Nora) Lad, MD, PhD

  • Giacomina (Mina) Massaro-Giordano, MD

  • Iqbal Ike K. Ahmed, MD, FRCSC

  • Leanne T. Labriola, DO, MBA

  • Marion R. Munk, MD, PhD, FEBO

  • Mark Hinds, BScApp(Optom), GradCertOcTher, FBCLA, FIAOMC

  • Mark Pennesi, MD, PhD, FARVO

  • Michael Goldstein, MD, MM

  • Susan Benton, MBA

  • Patricio G. Schlottmann, MD

  • Victor L. Perez, MD

The committee represents an evolution of the traditional Scientific Advisory Board model, offering a more defined framework for applying expert perspectives directly to real-world development challenges facing innovators. By combining Ora’s deep therapeutic, operational, and regulatory expertise with the knowledge of leading clinicians and researchers around the world, the CIC helps sponsors navigate uncertainty and move programs forward with greater precision and confidence.

“The ophthalmology landscape is becoming increasingly complex,” said Gus De Moraes, MD, PhD, MPH, Chief Medical Officer at Ora. “We created the Clinical Intelligence Committee to bring together some of the most respected experts in our field and give innovators direct access to practical, experience-based guidance when it matters most. Combined with Ora’s development expertise, the CIC helps teams gain clarity, reduce risk, and make better decisions for patients.”

The Clinical Intelligence Committee extends Ora’s ophthalmology expertise with additional perspectives from a global, multidisciplinary group of key opinion leaders representing diverse geographies, subspecialties, and clinical experiences. Through collaborative discussions grounded in real-world practice and research, the committee helps innovators evaluate development opportunities and address challenges before they become barriers to success.

“Some of the most important development decisions are made long before a trial begins,” said John Trein, MD, Ora Therapeutic Lead, Posterior. “Choices around study design, endpoints, patient populations, and operational execution can ultimately shape the trajectory of an entire program. The strength of the Clinical Intelligence Committee is the diversity of experience around the table. Sponsors gain direct access to experts who can help identify opportunities, uncover risks, and refine strategies based on decades of clinical and development experience.”

The launch of the Clinical Intelligence Committee reinforces Ora’s commitment to helping sponsors bring innovative ophthalmic therapies and technologies to patients more efficiently and effectively. By transforming expert insight into actionable development guidance, the CIC provides a new pathway for sponsors to strengthen programs and advance innovation with confidence.

Learn more about our new committee members at www.oraclinical.com/clinical-intelligence-committee.

About Ora

Ora is the world’s leading full-service ophthalmic drug and device CRO with employees in over 20 countries around the world. For over 50 years, we have proudly helped our clients earn more than 90 ophthalmic product approvals. We support a wide array of innovators and organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring new products from concept to market. Ora’s unique methodologies, clinical models, and regulatory strategies have been refined and proven across thousands of global projects. For more information, please visit www.oraclinical.com and follow us on LinkedIn.

Media gallery

About The Author
Business Wire